The store will not work correctly when cookies are disabled.
Biological Data
|
Biological description
|
Akt (PKB) inhibitor. Binds at an allosteric site. Interferes with PH domain-PIP3 binding and enhances Akt ubiquitination. Blocks mTORC1/2, decreases glucose uptake and cell viability. Shows anti-tumor actions. |
Solubility & Handling
|
Storage instructions
|
-20°C |
|
Solubility overview
|
Soluble in DMSO (75mM) or ethanol (75mM) |
|
Important
|
This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use. Not for human or veterinary use. |
Chemical Data
|
Chemical name
|
(2E,6E)-2,6-Bis(4-pyridinylmethylene)cyclohexanone |
|
Chemical structure
|
|
|
Molecular Formula
|
C18H16N2O |
|
PubChem identifier
|
6018993 |
|
SMILES
|
O=C(/C(CCC3)=C/C2=CC=NC=C2)/C3=C/C1=CC=NC=C1 |
|
InChiKey
|
CYVVJSKZRBZHAV-UNZYHPAISA-N |
References for SC 66
References are publications that support the biological activity of the product
-
AKT inhibitors promote cell death in cervical cancer through disruption of mTOR signaling and glucose uptake.
Rashmi R et al (2014)
PLoS One 9(4) : e92948.
-
Deactivation of Akt by a small molecule inhibitor targeting pleckstrin homology domain and facilitating Akt ubiquitination.
Jo H et al (2011)
Proc Natl Acad Sci U S A 108(16) : 6486-91.